Quarterly report pursuant to Section 13 or 15(d)

REVENUES - Disaggregated (Details)

v3.23.1
REVENUES - Disaggregated (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Disaggregation of Revenue [Line Items]    
Total revenues $ 26,070 $ 16,735
Gross product sales    
Disaggregation of Revenue [Line Items]    
Total revenues 33,198 22,618
Discounts and allowances    
Disaggregation of Revenue [Line Items]    
Total revenues (9,453) (6,421)
Product sales, net    
Disaggregation of Revenue [Line Items]    
Total revenues 23,745 16,197
License revenues    
Disaggregation of Revenue [Line Items]    
Total revenues   208
Royalty, delivery of drug supplies and others    
Disaggregation of Revenue [Line Items]    
Total revenues 2,325 330
Contract revenues from collaborations    
Disaggregation of Revenue [Line Items]    
Total revenues $ 2,325 $ 538